18.32 USD
▲+0.01+0.05%
盘后 18.29 -0.16%
2026-11-19
市值
$966.23M
市盈率
—
EPS
-5.86
股息率
—
52 周区间
14.85 – 28.38
成交量
321.04K
Beta
—
目标价
37.13
52W 低 14.8552W 高 28.38
价格走势
公司简介
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety. The company’s lead product candidate, GlyphAllo (SPT-300 or Glyph Allopregnanolone), is a novel, Glyphed oral prodrug of allopregnanolone, an endogenous molecule that has been clinically validated in third-...